Growth Metrics

Nektar Therapeutics (NKTR) Revenue Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 122.97%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.94%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 4.47%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 54.05%
10 Nektar Therapeutics 1.60 Bn 1.04 Bn 3.16 Mn -20.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.47%
Dec 31, 2025 -0.33%
Sep 30, 2025 -20.68%
Jun 30, 2025 -19.70%
Mar 31, 2025 -25.03%
Dec 31, 2024 5.27%
Sep 30, 2024 -1.08%
Jun 30, 2024 -6.06%
Mar 31, 2024 -2.91%
Dec 31, 2023 0.60%
Sep 30, 2023 -7.02%
Jun 30, 2023 -25.13%
Mar 31, 2023 -24.70%
Dec 31, 2022 -13.36%
Sep 30, 2022 -6.84%
Jun 30, 2022 -2.54%
Mar 31, 2022 -4.19%
Dec 31, 2021 35.74%
Sep 30, 2021 -3.53%
Jun 30, 2021 -70.36%
Mar 31, 2021 -14.64%
Dec 31, 2020 -37.36%
Jun 30, 2020 12.19%
Mar 31, 2020 26.93%
Dec 31, 2019 35.24%
Sep 30, 2019 -7.01%
Jun 30, 2019 -10.73%
Mar 31, 2019 -21.74%
Dec 31, 2018 -36.67%
Sep 30, 2018 -22.63%
Jun 30, 2018 263.42%
Mar 31, 2018 68.31%
Dec 31, 2017 133.90%
Jun 30, 2017 81.32%
Mar 31, 2017 7.74%
Dec 31, 2016 -23.97%
Sep 30, 2016 -15.82%
Jun 30, 2016 46.96%
Mar 31, 2016 36.79%
Dec 31, 2015 23.02%
Sep 30, 2015 48.22%
Jun 30, 2015 -1.46%
Mar 31, 2015 4.71%
Dec 31, 2014 -22.10%
Sep 30, 2014 -39.16%
Jun 30, 2014 -30.56%
Mar 31, 2014 20.50%
Dec 31, 2013 42.78%
Sep 30, 2013 17.11%
Jun 30, 2013 -37.64%
Mar 31, 2013 -11.54%